Innovative 'Montreal Model' Enhances Durability of Ketamine-Based Depression Treatment
The Montreal Model of ketamine therapy combines psychotherapy and supportive environments, leading to more sustained relief from severe depression and treatment resistance.
Recent clinical research led by McGill University introduces the 'Montreal Model,' a novel approach to ketamine therapy for severe depression. The study demonstrates that combining ketamine infusions with psychotherapy and a therapeutic environment significantly extends the duration of antidepressant effects. Participants with treatment-resistant depression, many experiencing suicidal thoughts, showed an average depression score reduction of approximately 30%, with improvements in suicidality and anxiety. Notably, these effects persisted for at least eight weeks, unlike conventional ketamine treatments where benefits often diminish within days.
The study emphasizes the importance of the treatment environment—rooms designed with calming lighting, plants, curated music or guided mindfulness—alongside regular psychotherapy sessions. This approach underscores the significance of psychological context in treatment outcomes.
Developed during residencies at McGill by Dr. Greenway and Dr. Garel, the Montreal Model integrates traditional psychiatry with strategies inspired by psychedelic therapy, including creating safe, supportive spaces for patients. The model has been successfully applied in both public and private healthcare settings in Canada and internationally.
An intriguing aspect of the research is the link between the subjective mystical or emotional experiences during ketamine sessions and positive therapeutic outcomes. These findings challenge the traditional view of such experiences as mere side effects, suggesting they may be integral to the healing process.
The study's positive results support the adoption of structured, environment-centric ketamine treatments, offering a promising path for managing complex, treatment-resistant depression. It also highlights the need for standardized protocols as ketamine clinics proliferate across Canada and beyond.
For further information, see the original source at
https://medicalxpress.com/news/2025-06-montreal-ketamine-therapy-yields-sustained.html
source: https://medicalxpress.com/news/2025-06-montreal-ketamine-therapy-yields-sustained.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Impact of COVID-19 Declaration of State of Alarm on Memory, Especially Among Young People
A recent study reveals that the declaration of a COVID-19 state of alarm created powerful flashbulb memories across all ages, with the youngest recalling the most details, highlighting the profound emotional impact of the pandemic.
Understanding What Matters Most to Suicidal Teenagers
Exploring the personal reasons that motivate suicidal teens to stay alive reveals the importance of relationships, future aspirations, and personal goals in fostering hope and resilience. Understanding these motivators can enhance mental health interventions.
New Insights into Psychedelic Use and Trauma Recovery Among Nova Festival Survivors
A groundbreaking study reveals that survivors of the Nova Festival terrorist attack experienced lower anxiety and PTSD symptoms after using classic psychedelics. Explore the implications for trauma therapy.
Racial and Ethnic Disparities in Adolescent Mental Health Service Usage
A new study reveals significant racial and ethnic disparities in adolescent mental health service utilization in the U.S., underscoring the need for equitable access to care.